Your email has been successfully added to our mailing list.

×
-0.000350631136044894 -0.000467508181393081 -0.00151940158952776 -0.000993454885460422 -0.00274661056568489 -0.0017531556802243 -0.00257129499766245 -0.00227910238429165
Stock impact report

Immunomedics' trodelvy shows 27% response rate in urothelial cancer [Seeking Alpha]

IMMUNOMEDICS (IMMU) 
Last immunomedics earnings: 2/27 04:00 pm Check Earnings Report
Company Research Source: Seeking Alpha
HealthcareImmunomedics' trodelvy shows 27% response rate in urothelial cancerSep. 21, 2020 9:05 AM ET|Immunomedics, Inc. (IMMU)Vandana Singh(NASDAQ:announced positiveResults confirmed the interim findings and prior Phase 1/2 study results showing Trodelvy has significant activity and is safe in patients with heavily-pretreated mUC who progressed on both platinum-based chemotherapy and checkpoint inhibitors.As of data cutoff on May 18, 8 of the 31 responders have an ongoing response and remain on treatment.Trodelvy achieved a 27% overall response rate and a 5.9-month median duration of response in heavily-pretreated mUC patients. Median progression-free survival was 5.4 months with median overall survival of 10.5 months.On safety front, Trodelvy demonstrated to be tolerable. Serious/severe treatment-related adverse events were mostly hematologic and gastrointestinal related, including neutropenia, low level of type of white blood cells called neutrophils (34%) and diarrhea (10%). Seve Show less Read more
Impact Snapshot
Event Time:
IMMU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for IMMU alerts
Opt-in for
IMMU alerts

from News Quantified
Opt-in for
IMMU alerts

from News Quantified